New York

Aperture Venture Partners is a healthcare-focused investment firm. We are committed to working with exceptional entrepreneurs to build innovative companies in the medical device, pharmaceutical, healthcare IT/services and diagnostic sectors. Our partners have deep industry knowledge and a track record of success in helping outstanding companies realize their potential.

Aperture has invested in several companies that have achieved valuations exceeding $1 billion (Biohaven Pharmaceuticals, Inspire Medical, Axonics, Tarsus Pharmaceuticals, Mako Surgical, Cameron Health, Conor Medsystems, Collegium Pharmaceutical, Aclaris Therapeutics).